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Methods
Ten eyes in 10 patients with refractory glaucoma, with 
high intraocular pressure on maximum antiglaucomatous 
medical therapy. Four patients had pseudoexpholiative 
glaucoma, 3 neovascular glaucoma, 1 secondary glaucoma 
and 3 patients with primary open angle glaucoma that 
already had trabeculectomy. We used parabulbar anesthe-
sia with supplemental intracameral lidocaine injection. 
We performed shunt implantation in standard procedure 
without complications, implants were well positioned. In 
3 patients we performed combined two-site surgery PHA-
CO with implantation of acrylic IOL followed by fi ltrating 
surgery – Ex-PRESS miniature glaucoma shunt implanta-
tion. All surgery was performed by the same surgeon, in 
Department of Ophthalmology, General Hospital Zadar. 
Postoperatively we recommended combined antibiotic and 
steroid drops every four hours in the fi rst week followed 
by taper. Evaluated parameters were intraocular pres-
sure, visual acuity and slit lamp examination on 1st, 7th 
postoperative day, 1 month and monthly 4 months after 
surgery.
Results
Baseline intraocular pressure was 32–56 mmHg, base-
line visual acuity was light perception in 4 patients, hand 
Introduction
Refractory glaucoma is an uncommon type of glaucoma 
that is diffi cult or nearly impossible to treat. It is a case of 
glaucoma with high intraocular pressure (IOP), medi-
cally uncontrolled. Previous failed guarded fi ltering sur-
gery (trabeculectomy) is also characterized as refractory. 
The main characteristic of this tipe of glaucoma is its great 
resistance to IOP reduction with traditional medical or 
surgical treatment. All tipes of glaucoma can be refrac-
tory, primary or secondary, open angle or angle closure 
glaucoma. There are different types of surgical manage-
ment of refractory glaucoma-tubes and valves implanta-
tion- Ahmed glaucoma valve implantation, Molteno valve, 
Baerveldt implant, Ex-PRESS miniature glaucoma shunt, 
destructive procedures-ND:Yag laser and diode laser cy-
clophotocoagulation. Shunt devices are introduced as an 
alternate means to improve poor long termed outcomes of 
trabeculectomy particularly in refractory glaucoma cases1. 
Ex- PRESS minature glaucoma shunt device shunts aque-
ous from the anterior chamber to a subconjunctival space 
in a similar way as terabeculectomy2. It is a non valved 3 
mm long device, external diameter aprox. 400 microns3. 
It is implanted under a scleral fl ap4. The advantages of 
Ex-PRESS miniature glaucoma shunt are atraumatic im-
plantation, less complications and infl amation, low diffuse 
blebs and high success rate.
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A B S T R A C T
Refractory glaucoma in a complicated type of glaucoma of different ethyologies with one same characteristic – intra-
ocular pressure of great resistance to therapy. There are different methods of treatment in such glaucomas, primary surgi-
cal options. Ex-PRESS miniature glaucoma shunt implantation was our treatment of choice. In our group of patients we 
achieved stabile intraocular pressure values in 4 month period of time with no serious or unexpected complications.
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motion in one patient and 0.01–0.08 in 5 patients. Intra-
ocular pressure in 1st postoperative day was 10–14 mmHg 
in 8 patients and 2 patients had hypotonia, visual acuity 
was light perception in 4 patients, hand motion in 1 pa-
tients and 0.03–0.08 in 5 patients, slit lamp examination 
showed fl at anterior chamber in 2 patients, shallow in 3 
patients and normal anterior chamber depth in 5 patients. 
Seventh postoperative day measured intraocular pressure 
was 10–20 mmHg, visual acuity was light perception in 4 
and hand movements in 1 patient, 0.03–0.1 in 5 patients, 
slit lamp examination showed shallow anterior chamber 
in 2 patients and normal anterior chamber depth in 8 pa-
tients. Four months after surgery intraocular pressure 
was 12–18 mmHg, visual acuity light perception in 4 pa-
tients, hand movements in 1 patient, 0.07–0.8 in 5 pa-
tients, slit lamp examination showed normal anterior 
chamber depth in all patients. None of the patient used 
any medical therapy 4 months after surgery. Table 1 pres-
ents patients fi ndings prior the procedure and in postop-
erative period during follow up. Table 2 presents only IOP 
fi ndings in the same period of time.
Discussion and Conclusion
The major objective of treatment in glaucoma is the 
decrease of IOP while maintaining the patient’s vision and 
quality of life. Despite the possibilities some types of glau-
coma remain refractory to treatment with remainance of 
high IOP and further progression of the disease5. Studies 
showed that shunt surgery and trabeculectomy with MMC 
are both viable surgical options for glaucoma patients who 
undergone prior failed fi ltering surgery6,7. Results of the 
Tube Versus Trabeculectomy Study (TVT Study) support 
the expanding use of tube shunts. The two most common-
ly use devices are Ahmad and Berveldt valve. Studies 
report similar baseline characteristics and similar num-
ber of intraoperative complications for both devices8,9. 
There also studies evaluating additional glaucoma drain-
TABLE 1
PATIENTS – PRE AND POSTOPERATIVE FINDING













Neo 1 No 38 LP 12 LP 16 LP 14 LP 16 LP
Neo 2 Yes 46 LP 14 LP 18 LP 18 LP 20 LP
Neo 3 Yes 48 LP 10 LP  Shall. AC 20 LP 16 LP 14 LP
Neo 4 No 56 LP   8 LP  Flat AC 18 LP Shall. AC 14 LP 18 LP
Pex1 Yes 40 0.01 14 0.08 16 0.1 12 0.4 16 0.5
Pex2 Yes 36 0.02 12 0.03 14   0.03 16 0.1 16 0.3
Pex3 No 38 HM   8 HM  Flat AC 18 HM Shall. AC 18 HM 18 HM
SEC glauc. No 32 0.05 10 0.05  Shall. AC 14   0.07 14   0.07 16   0.08
TTC Yes 40 0.05 14 0.07 12   0.08 16 0.8 16   0.08
TTC Yes 32 0.08 10 0.08  Shall. AC 10 0.1 14 0.3 16 0.4
M    40.6    11.2    15.6    15.2    16.6
s        7.47        2.35        3.10        1.93        1.65
M – arithmetic mean; s – standard deviation; Neo – neovascular; Pex – pseudoexpholiative; SEC – secondary; TTC – trabeculectomy; CAT – cataract; 
IOP – intraocular pressure; VA – visual acuity; LP – light perception; HM – hand motion
TABLE 2
IOP VALUES








baseline IOP IOP IOP IOP
Neo 1 38 12 16 14 16
Neo 2 46 14 18 18 20
Neo 3 48 10 20 16 14
Neo 4 56   8 18 14 18
Pex1 40 14 16 12 16
Pex2 36 12 14 16 16
Pex3 38   8 18 18 18
SEC glauc. 32 10 14 14 16
TTC 40 14 12 16 16
TTC 32 10 10 14 16
M    40.6    11.2    15.6    15.2    16.6
s        7.49        2.35        3.10        1.93        1.65
M – arithmetic mean; s – standard deviation, Neo – neovascular, Pex – 
pseudoexpholiative, SEC – secondary, TTC – trabeculectomy, IOP – in-
traocular pressure
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age implant (GDD) insertion in eyes with refractory glau-
comas that have failed primary GDD. Those studies agree 
that the GDD insertion is the best option in treating re-
fractory glaucoma even in cases of failed primary GDD10. 
Ex-PRESS miniature glaucoma shunt is an alternative in 
anti-glaucoma surgery11. Standard trabeculectomy and 
Ex-PRESS shunt are reported to have similar effi cacy and 
safety profi le while the cost of the shunt can make its use 
unjustifi ed, especially as a primary procedure12. In some 
glaucoma cases not responding to maximum antiglaucoma 
therapy as in cases of prior and unsuccessful trabeculec-
tomy the implantation of Ex-PRESS miniature glaucoma 
shunt is effective in lowering of intraocular pressure as 
the main expected outcome of the procedure. There are 
also reports of comparison of using MMC or Ologen with 
Ex-PRESS – they suggest similar surgical success in both 
cases13. In our cases we used Ex-PRESS miniature glau-
coma shunt with MMC in group of refractory glaucoma 
cases of different etiologies. In all cases we achieved the 
desired result – lowering the intraocular pressure and 
avoiding any topical antiglaucomatous therapy. Visual 
acuity after surgery was the same or better, especially in 
patients with combined cataract surgery and shunt im-
plantation. We also had no unexpected adverse effects and 
complications confi rming excellent safety profi le.
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EX-PRESS MINIATURE GLAUKOMA SHUNT U TERAPIJI REFRAKTERNOG GLAUKOMA
S A Ž E T A K
Refrakterni glaukom je komplicirani glaukom, različite etiologije. Zajednička karakteristika svih tipova refrakternig 
glaukoma je povišen intraokularni tlak koji ne reagira na terapiju. Različite su metode liječenja takvog tipa glaukoma 
uglavnom operativne. Impalntacija Ex-PRESS miniature glaukoma shunta bila je naša metoda izbora. U našoj grupi 
pacijenata nakon operacije i u periodu praćenja od 4 mjeseca postigli smo stabilne vrijednosti intraokularnog tlaka bez 
neočekivanih komplikacija.
